Stephen P Macmillan's most recent trade in Hologic, Inc. was a trade of 6,860 Common Stock done at an average price of $77.5 . Disclosure was reported to the exchange on Nov. 14, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share. | 14 Nov 2024 | 6,860 | 1,234,278 (0%) | 0% | 77.5 | 531,924 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 117,801 | 117,801 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share. | 07 Nov 2024 | 68,447 | 1,201,461 (0%) | 0% | 78.8 | 5,390,886 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 39,677 | 1,241,138 (0%) | 0% | - | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share. | 07 Nov 2024 | 6,214 | 1,269,908 (0%) | 0% | 79.3 | 492,708 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 118,560 | 1,276,122 (0%) | 0% | - | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. | 30 Jul 2024 | 44,039 | 1,201,601 (0%) | 0% | 26.2 | 1,154,262 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2024 | 44,039 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 82.32 per share. | 30 Jul 2024 | 20,228 | 1,157,562 (0%) | 0% | 82.3 | 1,665,169 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 81.44 per share. | 30 Jul 2024 | 16,177 | 1,177,790 (0%) | 0% | 81.4 | 1,317,455 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 80.60 per share. | 30 Jul 2024 | 7,634 | 1,193,967 (0%) | 0% | 80.6 | 615,300 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 3,672 | 44,039 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 80.13 per share. | 17 Jul 2024 | 3,672 | 1,157,562 (0%) | 0% | 80.1 | 294,223 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. | 17 Jul 2024 | 3,672 | 1,161,234 (0%) | 0% | 26.2 | 96,243 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 23 May 2024 | 57,875 | 1,157,213 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Stephen P. Macmillan | Director | 16 May 2024 | 2,622 | 4,129 (0%) | 0% | 0 | Common Stock | ||
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Apr 2024 | 12,000 | 1,215,088 (0%) | 0% | 0 | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Apr 2024 | 12,000 | 1,227,088 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Stephen P. Macmillan | Director | 01 Jun 2023 | 1,507 | 1,507 (0%) | 0% | 0 | Common Stock | ||
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 75.43 per share. | 30 Nov 2022 | 20,999 | 2,326,471 (0%) | 0% | 75.4 | 1,584,039 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 76.02 per share. | 30 Nov 2022 | 12,501 | 2,313,970 (0%) | 0% | 76.0 | 950,326 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. | 09 Nov 2022 | 96,355 | 2,347,470 (0%) | 0% | 75.9 | 7,316,235 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. | 09 Nov 2022 | 95,422 | 2,539,247 (0%) | 0% | 26.2 | 2,501,011 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2022 | 95,422 | 95,422 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 75.57 per share. | 09 Nov 2022 | 52,529 | 2,486,718 (0%) | 0% | 75.6 | 3,969,564 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 75.64 per share. | 09 Nov 2022 | 43,000 | 2,443,825 (0%) | 0% | 75.6 | 3,252,520 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 75.94 per share. | 09 Nov 2022 | 42,893 | 2,443,825 (0%) | 0% | 75.9 | 3,257,294 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. | 09 Nov 2022 | 5,776 | 2,486,825 (0%) | 0% | 72.1 | 416,507 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 106,300 | 106,300 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 36,987 | 2,496,653 (0%) | 0% | - | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. | 07 Nov 2022 | 4,052 | 2,492,601 (0%) | 0% | 73.7 | 298,673 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 103,447 | 2,459,666 (0%) | 0% | - | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share. | 11 Nov 2021 | 91,777 | 2,355,893 (0%) | 0% | 73.5 | 6,749,281 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share. | 11 Nov 2021 | 7,345 | 2,447,670 (0%) | 0% | 72.6 | 533,320 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 118,877 | 118,877 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 35,146 | 2,459,188 (0%) | 0% | - | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. | 08 Nov 2021 | 4,173 | 2,455,015 (0%) | 0% | 71.3 | 297,368 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 240,732 | 2,424,042 (0%) | 0% | - | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Sep 2021 | 15,000 | 2,188,217 (0%) | 0% | 0 | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Sep 2021 | 5,250 | 2,182,967 (0%) | 0% | 0 | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share. | 01 Dec 2020 | 439,919 | 2,203,217 (0%) | 0% | 69.6 | 30,631,560 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share. | 12 Nov 2020 | 8,179 | 2,643,136 (1%) | 0% | 70.2 | 574,166 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 123,801 | 123,801 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 36,199 | 2,658,948 (1%) | 0% | - | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share. | 09 Nov 2020 | 7,633 | 2,651,315 (1%) | 0% | 69.8 | 533,089 | Common Stock |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 900,307 | 2,622,749 (0%) | 0% | - | Common Stock | |
| Boston Scientific | Stephen P. Macmillan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 498 | 8,000 (0%) | 0% | 0 | Common Stock |